Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies

被引:0
|
作者
Boulos Haraoui
Gustavo Casado
László Czirják
Andrew Taylor
Lingli Dong
Peter Button
Yves Luder
Roberto Caporali
机构
[1] Institut de Rhumatologie de Montréal,Department of Rheumatology
[2] Hospital Militar Central,Rheumatology and Immunology Clinic, Medical Center
[3] University of Pécs,Medicine and Pharmacology RPH Unit, Royal Perth Hospital
[4] University of Western Australia,Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College
[5] Huazhong University of Science and Technology,Department of Rheumatology
[6] OzBiostat Pty Ltd,undefined
[7] F. Hoffmann-La Roche,undefined
[8] Ltd,undefined
[9] University of Pavia,undefined
[10] IRCCS S. Matteo Foundation,undefined
来源
Rheumatology and Therapy | 2019年 / 6卷
关键词
ACT-UP; Biologic factors; Rheumatoid arthritis; Tocilizumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:231 / 243
页数:12
相关论文
共 38 条
  • [1] Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies
    Haraoui, Boulos
    Casado, Gustavo
    Czirjak, Laszlo
    Taylor, Andrew
    Dong, Lingli
    Button, Peter
    Luder, Yves
    Caporali, Roberto
    RHEUMATOLOGY AND THERAPY, 2019, 6 (02) : 231 - 243
  • [2] Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies
    Haraoui, B.
    Casado, G.
    Czirjak, L.
    Taylor, A.
    Bernasconi, C.
    Reiss, W.
    Caporali, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 899 - 906
  • [3] ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis
    Specker, C.
    Alberding, A.
    Aringer, M.
    Burmester, G-R
    Flacke, J-P
    Hofmann, M. W.
    Kaestner, P.
    Kellner, H.
    Moosig, F.
    Sieburg, M.
    Tony, H-P
    Fliedner, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : 319 - 328
  • [4] Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
    Siegfried Wassenberg
    Rolf Rau
    Thilo Klopsch
    Anja Plenske
    Jürgen Jobst
    Pascal Klaus
    Thomas Meng
    Peter-Andreas Löschmann
    Rheumatology and Therapy, 2023, 10 : 117 - 133
  • [5] Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
    Wassenberg, Siegfried
    Rau, Rolf
    Klopsch, Thilo
    Plenske, Anja
    Jobst, Juergen
    Klaus, Pascal
    Meng, Thomas
    Loeschmann, Peter-Andreas
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 117 - 133
  • [6] ROUTINE-a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in Germany
    Iking-Konert, Christof
    von Hinueber, Ulrich
    Richter, Constanze
    Schwenke, Holger
    Guertler, Irmgard
    Kaestner, Peter
    Klapperich, Birgit
    Peters, Marvin A.
    Burmester, Gerd-Ruediger
    RHEUMATOLOGY, 2016, 55 (04) : 624 - 635
  • [7] Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis
    Kihara, Mari
    Davies, Rebecca
    Kearsley-Fleet, Lianne
    Watson, Kath D.
    Lunt, Mark
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    CLINICAL RHEUMATOLOGY, 2017, 36 (02) : 241 - 250
  • [8] Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis
    Mari Kihara
    Rebecca Davies
    Lianne Kearsley-Fleet
    Kath D. Watson
    Mark Lunt
    Deborah P.M. Symmons
    Kimme L. Hyrich
    Clinical Rheumatology, 2017, 36 : 241 - 250
  • [9] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Kumar, Namita
    Naz, Sophia
    Quinn, Mark
    Ryan, John
    Kumke, Thomas
    Sheeran, Tom
    ADVANCES IN THERAPY, 2018, 35 (09) : 1426 - 1437
  • [10] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Namita Kumar
    Sophia Naz
    Mark Quinn
    John Ryan
    Thomas Kumke
    Tom Sheeran
    Advances in Therapy, 2018, 35 : 1426 - 1437